Polarean Imaging (LSE:POLX) EBIT : £-11.54 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging EBIT?

Polarean Imaging's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2023 was £-5.82 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was £-11.54 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Polarean Imaging's annualized ROC % for the quarter that ended in Jun. 2023 was -325.78%. Polarean Imaging's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -754.70%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Polarean Imaging's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -2,068.64%.

Polarean Imaging EBIT Historical Data

The historical data trend for Polarean Imaging's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging EBIT Chart

Polarean Imaging Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

-4.16

-4.59

-4.92

-10.52

-11.40

Polarean Imaging Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT	Get a 7-Day Free Trial								-3.46	-6.88	-5.61	-5.73	-5.82

Competitive Comparison of Polarean Imaging's EBIT

For the Medical Devices subindustry, Polarean Imaging's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polarean Imaging's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's EV-to-EBIT falls into.

Polarean Imaging EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-11.54 Mil.

Polarean Imaging (LSE:POLX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Polarean Imaging's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-12.044 * ( 1 - 0% )	/	( (4.504	+	2.89)	/ 2 )
=	-12.044	/	3.697
=	-325.78 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	18.503	-	0.49	-	( 13.509	-	max(0, 1.815	-	16.276	+	13.509	))
=	4.504

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	12.434	-	1.719	-	( 7.825	-	max(0, 1.936	-	10.65	+	7.825	))
=	2.89

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Polarean Imaging's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-11.63	/	( ( (0.569 + max(1.069, 0))	+	(0.446 + max(0.998, 0)) )	/	2 )
=	-11.63	/	( ( 1.638	+	1.444 )	/	2 )
=	-11.63	/	1.541
=	-754.70 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.089	+	1.405	+	1.273)	-	(0.49	+	0	+	1.208)
=	1.069

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.192	+	1.633	+	0)	-	(1.719	+	0	+	0.108)
=	0.998

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Polarean Imaging's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	-11.543	/	0.558
	=	-2,068.64 %

Polarean Imaging EBIT Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Polarean Imaging (LSE:POLX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

PLLWF:USA 8ZF:Germany

Address

27-28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.polarean.com

Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines